Clinical Trial: Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673445) titled 'Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism' on May 27.

Brief Summary: The goal of this clinical trial is to evaluate whether an intensive blood pressure control strategy (systolic blood pressure target <120 mmHg) is more effective than a standard strategy (systolic blood pressure target <140 mmHg) in reducing the risk of cardiovascular events in patients with primary aldosteronism.

The main question it aims to answer is: Does the intensive blood pressure control strategy reduce the risk of composite cardiovascular events more than the standard strategy in patients with primary aldosteronism? The study em...